Rigel Pharmaceuticals regains rights as Lilly terminates license deal
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1281.91 +2.77 (0.22%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1279.14 | 52 Week High | $88.16 | |||
| Open | $1273.50 | 52 Week Low | $67.88 | |||
| Day High | $1297.92 | P/E | 296.74 | |||
| Day Low | $1272.07 | EPS | $4.32 | |||
| Volume | 1,849,398 | |||||
| Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) | Delayed: 50.55 +0.64 (1.28%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $49.91 | 52 Week High | $4.38 | |||
| Open | $50.09 | 52 Week Low | $1.88 | |||
| Day High | $50.70 | P/E | N/A | |||
| Day Low | $49.54 | EPS | $-1.12 | |||
| Volume | 133,101 | |||||
